Abbott's New Leadless Pacemaker System Meets Primary Endpoints in Pivotal Trial
Go back to Abbott's New Leadless Pacemaker System Meets Primary Endpoints in Pivotal Trial| Abbott Laboratories (NYSE: ABT) | Delayed: 109.72 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $109.72 | 52 Week High | $46.38 | |||
| Open | $109.72 | 52 Week Low | $36.00 | |||
| Day High | $109.72 | P/E | 73.15 | |||
| Day Low | $109.72 | EPS | $1.50 | |||
| Volume | 5,075 | |||||
